[PDF][PDF] One year in review 2022: systemic lupus erythematosus

…, E Elefante, D Schilirò, V Signorini, F Trentin… - Clin Exp …, 2022 - researchgate.net
Systemic lupus erythematosus (SLE) is a chronic multisystem auto-immune disease with
extremely varied clinical manifestations and a complex pathogenesis. New insights in SLE …

Systemic lupus erythematosus: one year in review 2023

…, E Elefante, V Signorini, C Cardelli, F Trentin… - Clinical and …, 2023 - sfera.unife.it
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a wide range of
clinical manifestations and a relapsing-remitting course. New data regarding pathogenic …

[HTML][HTML] Effectiveness, tolerability, and safety of belimumab in patients with refractory SLE: a review of observational clinical-practice-based studies

F Trentin, M Gatto, M Zen, L Maddalena… - Clinical Reviews in …, 2018 - Springer
To date, belimumab is the only biological drug approved for the treatment of patients with
active refractory SLE. We compared and critically analyzed the results of 11 observational …

[PDF][PDF] One year in review 2021: systemic lupus erythematosus

F Trentin, D Zucchi, V Signorini, E Elefante… - Clin Exp …, 2021 - clinexprheumatol.org
In 2020 many contributions have been produced on SLE. Our critical digest of the recent
literature will be focused on genetic factors that contribute to the development of the disease, …

[PDF][PDF] One year in review 2020: systemic lupus erythematosus

V Signorini, E Elefante, D Zucchi, F Trentin… - Clin Exp …, 2020 - researchgate.net
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a relapsing-remitting
course that can affect various organs or systems, leading to a broad spectrum of clinical …

[HTML][HTML] Impact of first wave of SARS-CoV-2 infection in patients with systemic lupus erythematosus: weighting the risk of infection and flare

…, C Stagnaro, L Carli, V Signorini, F Ferro, F Trentin… - PLoS …, 2021 - journals.plos.org
Introduction The aim of this study was to investigate the incidence and clinical presentation
of SARS-CoV-2 infections in a Systemic Lupus Erythematosus (SLE) cohort; to assess …

[PDF][PDF] One year in review 2020: vasculitis

…, M Bond, S Monti, E Elefante, F Trentin… - Clin Exp …, 2020 - clinexprheumatol.org
Systemic vasculitides are a group of diseases that could potentially affect any organ with
heterogeneous clinical manifestations that usually depend on the size of the most involved …

Treatment with anifrolumab for discoid lupus erythematosus

F Trentin, C Tani, E Elefante, C Stagnaro… - JAMA …, 2023 - jamanetwork.com
Discussion| In conclusion, in a real-life setting, treatment with ANI yielded rapid improvement
of discoid lesions with good tolerability. The effect was maintained over time, and the …

The effectiveness of median nerve electrical stimulation in patients with disorders of consciousness: a systematic review

D Feller, C Vinante, F Trentin, T Innocenti - Brain Injury, 2021 - Taylor & Francis
Objective To examine the effectiveness of median nerve electrical stimulation on
consciousness level in subjects with disorders of consciousness. Methods Electronic databases …

Which extra-renal flare is 'difficult to treat'in systemic lupus erythematosus? A one-year longitudinal study comparing traditional and machine learning approaches

…, V Signorini, D Zucchi, C Cardelli, F Trentin… - …, 2024 - academic.oup.com
Objectives To describe phenotypes and outcomes of extra-renal flares in SLE, to identify
clusters of extra-renal flares based on baseline features, and to develop a machine learning (ML…